ED from prostate cancer hormone therapy treatable
(Reuters)
Reuters - A new study shows that a
substantial minority of men receiving so-called androgen
deprivation therapy, or ADT, for prostate cancer experience
erectile dysfunction (ED). However, many respond well to ED
therapy, doctors from Memphis have found.
http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20080711/hl_nm/ed_treatable_dc